Last update 08 May 2025

SCG Cell Therapy (Shanghai) Pte Ltd

Private Company|2018|Shanghai Shi, China|
www.scgcell.com

Overview

Tags

Digestive System Disorders
Neoplasms
Infectious Diseases
TCR-T Cell therapy

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Disease DomainCount
Neoplasms1
Infectious Diseases1
Top 5 Drug TypeCount
TCR-T Cell therapy1
Top 5 TargetCount
HPV E71

Related

1
Drugs associated with SCG Cell Therapy (Shanghai) Pte Ltd
SCG-142
Target
HPV E7
Mechanism
E7 inhibitors [+1]
Active Org.
SCG Cell Therapy Pte. Ltd.SCG Cell Therapy Pte. Ltd.
 [+2]
Originator Org.
SCG Cell Therapy Pte. Ltd.SCG Cell Therapy Pte. Ltd.
Active Indication
Human Papillomavirus-Related Anal Squamous Cell Carcinoma [+8]
Inactive Indication-
Drug Highest PhasePhase 1/2
First Approval Ctry. / Loc.-
First Approval Date-
1
Clinical Trials associated with SCG Cell Therapy (Shanghai) Pte Ltd
CTR20251265
/ Not yet recruitingPhase 1
评估SCG142自体T细胞注射液治疗复发或转移性HPV16或HPV52相关恶性肿瘤的安全性和初步疗效的开放、单臂、多中心的I期研究
[Translation] An open, single-arm, multicenter phase I study to evaluate the safety and preliminary efficacy of SCG142 autologous T cell injection in the treatment of recurrent or metastatic HPV16 or HPV52-related malignancies
100 Clinical Results associated with SCG Cell Therapy (Shanghai) Pte Ltd
Login to view more data
0 Patents (Medical) associated with SCG Cell Therapy (Shanghai) Pte Ltd
Login to view more data
100 Deals associated with SCG Cell Therapy (Shanghai) Pte Ltd
Login to view more data
100 Translational Medicine associated with SCG Cell Therapy (Shanghai) Pte Ltd
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 12 May 2025

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Preclinical
1
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
SCG-142
 ( HPV E7 )		HPV-related carcinoma
More
Preclinical
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free